Literature DB >> 16498066

Protective and destructive immunity in the periodontium: Part 2--T-cell-mediated immunity in the periodontium.

Y-T A Teng1.   

Abstract

Based on the results of recent research in the field and Part 1 of this article (in this issue), the present paper will discuss the protective and destructive aspects of the T-cell-mediated adaptive immunity associated with the bacterial virulent factors or antigenic determinants during periodontal pathogenesis. Attention will be focused on: (i) osteoimmunology and periodontal disease; (ii) some molecular techniques developed and applied to identify critical microbial virulence factors or antigens associated with host immunity (with Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis as the model species); and (iii) summarizing the identified virulence factors/antigens associated with periodontal immunity. Thus, further understanding of the molecular mechanisms of the host's T-cell-mediated immune responses and the critical microbial antigens related to disease pathogenesis will facilitate the development of novel therapeutics or protocols for future periodontal treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498066     DOI: 10.1177/154405910608500302

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  19 in total

Review 1.  Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists.

Authors:  Christopher W Cutler; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

2.  CD8+ Foxp3+ T Cells Affect Alveolar Bone Homeostasis via Modulating Tregs/Th17 During Induced Periodontitis: an Adoptive Transfer Experiment.

Authors:  Y K Han; Y Jin; Y B Miao; T Shi; X P Lin
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 3.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

4.  Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis.

Authors:  Dalia E Gaddis; Craig L Maynard; Casey T Weaver; Suzanne M Michalek; Jannet Katz
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

5.  18β-glycyrrhetinic acid inhibits periodontitis via glucocorticoid-independent nuclear factor-κB inactivation in interleukin-10-deficient mice.

Authors:  H Sasaki; N Suzuki; E Alshwaimi; Y Xu; R Battaglino; L Morse; P Stashenko
Journal:  J Periodontal Res       Date:  2010-12       Impact factor: 4.419

6.  Inflammation and uncoupling as mechanisms of periodontal bone loss.

Authors:  D T Graves; J Li; D L Cochran
Journal:  J Dent Res       Date:  2010-12-06       Impact factor: 6.116

7.  Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats.

Authors:  Brian Bainbridge; Raj K Verma; Christie Eastman; Bilal Yehia; Mercedes Rivera; Catherine Moffatt; Indraneel Bhattacharyya; Richard J Lamont; Lakshmyya Kesavalu
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

8.  Suppression of T-cell chemokines by Porphyromonas gingivalis.

Authors:  Catherine E Jauregui; Qian Wang; Christopher J Wright; Hiroki Takeuchi; Silvia M Uriarte; Richard J Lamont
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

9.  Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.

Authors:  Xiaoxia Zhang; Mawadda Alnaeeli; Bhagirath Singh; Yen-Tung A Teng
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

10.  AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression.

Authors:  J A Cirelli; C H Park; K MacKool; M Taba; K H Lustig; H Burstein; W V Giannobile
Journal:  Gene Ther       Date:  2008-12-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.